Form 4: MindMed CEO Robert Barrow Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
MindMed's CEO, Robert Barrow, sold 19,771 common shares to cover withholding tax obligations related to vested restricted stock units.
Summary
- Robert Barrow, the CEO of Mind Medicine (MindMed) Inc., sold 19,771 common shares on September 25, 2024.
- The sale was executed to satisfy withholding tax obligations related to the settlement of vested restricted stock units.
- The shares were sold at a weighted average price of $5.98, with individual transactions ranging from $5.95 to $6.07.
- Following the transaction, Barrow still beneficially owns 545,772 common shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily reflect a change in the CEO's confidence in the company.
Industry Context
Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. These transactions are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- The sale of shares could have a minor impact on shareholders due to the slight dilution of equity.
- The transaction is unlikely to significantly affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| June 15, 2022 | Date of adoption of Rule 10b5-1 plan |
| September 25, 2024 | Date of transaction (share sale) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.